Biogened S.A. (WSE: BGD)
Poland
· Delayed Price · Currency is PLN 32.00
+5.80 (22.14%)
At close: Jan 30, 2025
Biogened Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 107.22 | 95.56 | 79.62 | 65.32 | 48.33 | 46.63 | Upgrade
|
| Revenue Growth (YoY) | 17.17% | 20.02% | 21.89% | 35.15% | 3.64% | 15.88% | Upgrade
|
| Cost of Revenue | 31.67 | 32.07 | 22.18 | 23 | 15.3 | 14.66 | Upgrade
|
| Gross Profit | 75.54 | 63.49 | 57.44 | 42.32 | 33.04 | 31.97 | Upgrade
|
| Selling, General & Admin | 64.33 | 54.62 | 41.86 | 35.29 | 30.02 | 28.27 | Upgrade
|
| Other Operating Expenses | 2.77 | 0.7 | 7.2 | 2.43 | 0.65 | 0.36 | Upgrade
|
| Operating Expenses | 67.1 | 55.32 | 49.06 | 37.73 | 30.68 | 28.62 | Upgrade
|
| Operating Income | 8.44 | 8.16 | 8.38 | 4.59 | 2.36 | 3.35 | Upgrade
|
| Interest Expense | -2.26 | -2.16 | -1.7 | -0.6 | -0.86 | -1.32 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.35 | 0 | -0.32 | -0.16 | 0.06 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | 5.84 | 6.01 | 6.36 | 3.84 | 1.55 | 1.93 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.49 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.71 | 0.88 | 0.03 | -0 | 0.62 | 0 | Upgrade
|
| Pretax Income | 6.55 | 6.89 | 6.39 | 4.33 | 2.18 | 1.93 | Upgrade
|
| Income Tax Expense | 1.68 | 1.79 | 3.01 | 2.37 | 0.93 | 0.66 | Upgrade
|
| Net Income | 4.87 | 5.1 | 3.38 | 1.96 | 1.24 | 1.27 | Upgrade
|
| Net Income to Common | 4.87 | 5.1 | 3.38 | 1.96 | 1.24 | 1.27 | Upgrade
|
| Net Income Growth | 28.61% | 50.74% | 72.46% | 57.92% | -2.37% | 11.84% | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| EPS (Basic) | 1.98 | 2.08 | 1.38 | 0.80 | 0.51 | 0.52 | Upgrade
|
| EPS (Diluted) | 1.98 | 2.08 | 1.38 | 0.80 | 0.51 | 0.52 | Upgrade
|
| EPS Growth | 28.61% | 50.74% | 72.46% | 57.92% | -2.37% | 11.84% | Upgrade
|
| Free Cash Flow | -1.41 | 7.72 | -3.35 | 1.57 | 6.88 | 1.87 | Upgrade
|
| Free Cash Flow Per Share | -0.57 | 3.14 | -1.36 | 0.64 | 2.80 | 0.76 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.400 | - | 0.200 | - | Upgrade
|
| Dividend Growth | 25.00% | 25.00% | - | - | - | - | Upgrade
|
| Gross Margin | 70.46% | 66.44% | 72.14% | 64.78% | 68.35% | 68.56% | Upgrade
|
| Operating Margin | 7.88% | 8.54% | 10.52% | 7.03% | 4.88% | 7.18% | Upgrade
|
| Profit Margin | 4.54% | 5.33% | 4.25% | 3.00% | 2.57% | 2.73% | Upgrade
|
| Free Cash Flow Margin | -1.32% | 8.08% | -4.21% | 2.41% | 14.23% | 4.01% | Upgrade
|
| EBITDA | 12.46 | 11.69 | 11.31 | 7.47 | 6.85 | 7.68 | Upgrade
|
| EBITDA Margin | 11.62% | 12.23% | 14.21% | 11.44% | 14.17% | 16.48% | Upgrade
|
| D&A For EBITDA | 4.02 | 3.52 | 2.94 | 2.88 | 4.49 | 4.34 | Upgrade
|
| EBIT | 8.44 | 8.16 | 8.38 | 4.59 | 2.36 | 3.35 | Upgrade
|
| EBIT Margin | 7.88% | 8.54% | 10.52% | 7.03% | 4.88% | 7.18% | Upgrade
|
| Effective Tax Rate | 25.65% | 26.01% | 47.09% | 54.71% | 42.95% | 34.03% | Upgrade
|
| Revenue as Reported | 107.22 | 95.56 | 79.62 | 65.32 | 48.33 | 46.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.